全球冠状动脉支架市场（2023-2030）：按产品类型（裸金属支架（BMS）/药物释放型支架（DES））和生物材料（生物材料/聚合物生物材料）分類的规模、份额、成长分析和预测

全球冠状动脉支架市场规模预计将从2021年的88亿美元成长到2022年的90.9亿美元，预测期内年复合成长率为3.3%，到2030年将达到117.9亿美元。

近年来，全球冠状动脉支架市场经历了显着的成长和进步。推动市场成长的主要因素包括心血管疾病盛行率的增加、老年人口的增加以及微创手术的日益采用。包括冠状动脉疾病在内的心血管疾病的增加导致对冠状动脉支架的需求增加。生活方式的改变、久坐的生活方式、不健康的饮食习惯等都会导致这些疾病的发生率增加。此外，老年人更容易患心血管疾病，进一步增加了对冠状动脉支架的需求。

支架设计的技术进步和创新显着改善了患者的治疗效果和安全性。药物释放型支架（DES）和生物可吸收支架的开发降低了血管再阻塞的风险并改善了长期结果。这些进步正在推动从传统的裸金属支架向药物释放型和生物可吸收支架的转变，从而推动市场成长。

另一方面，市场也面临一定的挑战。主要挑战之一是与冠状动脉支架置放术相关的高成本，包括支架本身和植入程序的成本。这可能会限制低收入地区和无力承担支架的患者采用支架。

本报告调查了全球冠状动脉支架市场，并提供了市场概况、市场各种影响因素分析、技术和创新趋势、法律制度、市场规模趋势和预测，以及各个细分市场和地区的细分。 、竞争形势、主要企业简介等。

目录

• 执行摘要
• 调查方法
• 母市场分析
  • 市场概况
  • 市场规模
  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
• 关键市场洞察
  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 贸易分析
  • 启动分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 总体经济指标
  • 重点投资分析
  • 关键成功因素
  • 竞争程度
  • 市场动态及展望
    • 市场动态
      • 促进因素
      • 机会
      • 抑制因素
      • 任务
  • 法规状况
  • 波特的分析
  • Skyquest 对未来颠覆的独家见解
• 全球冠状动脉支架市场：依产品类型
  • 裸金属支架（BMS）
  • 药物释放型支架（DES）
  • 生物可吸收支架（BVS）
• 全球冠状动脉支架市场：依生物材料分类
  • 市场概况
  • 生物材料
  • 高分子生物材料
  • 天然生物材料
• 全球冠状动脉支架市场：按地区
  • 市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲
• 竞争形势
  • 前5名企业对比
  • 主要企业市场地位
  • 主要企业的招募策略
  • 关键成功策略
  • 近期市集活动
  • 主要企业市场占有率
• 主要企业简介
  • Abbott Laboratories
  • Medtronic plc
  • Boston Scientific Corporation
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Johnson & Johnson
  • Cook Medical Inc.
  • CR Bard, Inc.
  • Biosensors International Group, Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Biotronik SE & Co. KG
  • Stentys SA
  • Hexacath
  • Translumina GmbH
  • Elixir Medical Corporation
  • Vascular Concepts
  • Alvimedica
  • InspireMD Inc.
  • Comed BV

Global Coronary Stent Market size was valued at USD 8.8 Billion in 2021 and is poised to grow from USD 9.09 Billion in 2022 to USD 11.79 Billion by 2030, at a CAGR of 3.3% during the forecast period (2023-2030).

The global coronary stent market has witnessed significant growth and advancements in recent years. The market growth is primarily driven by factors such as the increasing prevalence of cardiovascular diseases, rising geriatric population, and the growing adoption of minimally invasive procedures. The rise in cardiovascular diseases, including coronary artery disease, has led to a higher demand for coronary stents. Lifestyle changes, sedentary habits, and unhealthy diets contribute to the increasing incidence of these diseases worldwide. Additionally, the aging population is more susceptible to cardiovascular conditions, further fueling the demand for coronary stents. Technological advancements and innovations in stent designs have significantly improved patient outcomes and safety. The development of drug-eluting stents (DES) and bioresorbable stents has reduced the risk of restenosis and improved long-term results. These advancements have led to a shift from traditional bare-metal stents to drug-eluting and bioresorbable stents, driving market growth. However, the coronary stent market faces certain challenges. One of the major challenges is the high cost associated with coronary stent procedures, including the cost of stents themselves and the implantation procedure. This can limit the adoption of stents in lower-income regions or by patients with limited financial resources.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Coronary Stent Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Coronary Stent Market Segmental Analysis

The global coronary stent market is segmented on the basis of product, biomaterial, and region. By product, the market is segmented into Bare Metal Stents (BMS), Drug-Eluting Stents (DES), and Bioresorbable Vascular Scaffold (BVS). By biomaterial, the market is segmented into Biomaterials, Polymeric Biomaterials, and Natural Biomaterials. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Coronary Stent Market Dynamics

Drivers of the Global Coronary Stent Market

Increasing Prevalence of Cardiovascular Diseases

The rising incidence of cardiovascular diseases, including coronary artery disease, is a major driver for the global coronary stent market. Lifestyle changes, unhealthy diets, and sedentary lifestyles contribute to the growing burden of cardiovascular diseases globally.

Growing Aging Population

The aging population is more susceptible to cardiovascular conditions, leading to a higher demand for coronary stents. As the global population continues to age, the prevalence of cardiovascular diseases is expected to increase, driving the demand for coronary stents.

Restraints in the Global Coronary Stent Market

Stringent Regulatory Approval Processes

The stringent regulatory approval processes imposed by regulatory authorities can pose challenges for market growth. Manufacturers must comply with safety and efficacy assessments, which can be time-consuming and resource-intensive, delaying the market entry of new products.

Potential Complications

Stent implantation carries certain risks and potential complications, such as stent thrombosis, restenosis, and allergic reactions. These complications may affect patient outcomes and increase concerns among healthcare providers and patients, impacting market growth.

Market Trends of the Global Coronary Stent Key

Shift towards Minimally Invasive Procedures: There is a growing preference for minimally invasive procedures, including percutaneous coronary intervention (PCI), which drives the demand for coronary stents. Minimally invasive procedures offer benefits such as shorter hospital stays, reduced recovery time, and lower risk of complications compared to traditional open-heart surgeries.

Rising Focus on Patient-Specific Stenting: Personalized medicine and the concept of patient-specific stenting are gaining attention. Advanced imaging techniques, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are used to assess the morphology and dimensions of coronary arteries, allowing for customized stent selection and placement.

Table of Contents

• Executive Summary
  • Market Overview
  • Wheel of Fortune
• Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations
• Parent Market Analysis
  • Market Overview
  • Market Size
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
• Market Dynamics & Outlook
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Coronary Stent Market by Product Type
  • Market Overview
  • Bare Metal Stents (BMS)
  • Drug-Eluting Stents (DES)
  • and Bioresorbable Vascular Scaffold (BVS)
• Global Coronary Stent Market by Biomaterial
  • Market Overview
  • Biomaterials
  • Polymeric Biomaterials
  • and Natural Biomaterials
• Global Coronary Stent Market Size by Region
  • Market Overview
  • North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
  • Abbott Laboratories (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Medtronic plc (Ireland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Boston Scientific Corporation (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Terumo Corporation (Japan)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • B. Braun Melsungen AG (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Johnson & Johnson (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Cook Medical Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • C. R. Bard, Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Biosensors International Group, Ltd. (Singapore)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Meril Life Sciences Pvt. Ltd. (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • MicroPort Scientific Corporation (China)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Biotronik SE & Co. KG (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Stentys SA (France)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Hexacath (France)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Translumina GmbH (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Elixir Medical Corporation (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Vascular Concepts (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Alvimedica (Turkey)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • InspireMD Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Comed B.V. (Netherlands)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments